Insmed Inc Stock, NASDAQ:INSM
700 US Highway 202/206, Building 10, Bridgewater, New Jersey 08807-3365
United States of America
Number of Employees: 613
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.